![Sérgio Paulo de Magalhães Simões](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sérgio Paulo de Magalhães Simões
Directeur Général chez Luzitin SA
Postes actifs de Sérgio Paulo de Magalhães Simões
Sociétés | Poste | Début | Fin |
---|---|---|---|
Luzitin SA
![]() Luzitin SA Pharmaceuticals: MajorHealth Technology Luzitin SA provides photodynamic therapy and photodiagnosis solutions. The firm develops new compounds to improve the efficiency of photodynamic therapy in the treatment of cancer. The company was founded by Luís Arnaut in 2010 and is headquartered in Coimbra, Portugal. | Directeur Général | - | - |
Président | - | - | |
Bluepharma Indústria Farmacêutica SA
![]() Bluepharma Indústria Farmacêutica SA Pharmaceuticals: MajorHealth Technology Bluepharma Indústria Farmacêutica SA develops, manufactures, and markets pharmaceutical drugs The firm operates through the following business areas: Production of Pharmaceutical Drugs for Bluepharma and Other Companies; Research, Development, and Registration of Pharmaceutical Drugs; and Marketing of Generic Pharmaceutical Drugs. Its services include licensing, contract manufacturing, product development, and research and development. The company was founded in February 2001 and is headquartered in Coimbra, Portugal. | Directeur/Membre du Conseil | - | - |
Corporate Officer/Principal | - | - | |
Biocant Ventures SA
![]() Biocant Ventures SA Investment ManagersFinance Biocant Ventures SA (Biocant) is an Independent Venture Capital firm founded in 2006. The firm is headquartered in Cantanhede. | Directeur/Membre du Conseil | 01/01/2012 | - |
Private Equity Investor | 01/01/2012 | - | |
Treat U SA
![]() Treat U SA BiotechnologyHealth Technology Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal. | Président | 01/01/2010 | - |
Fondateur | 01/01/2010 | - |
Historique de carrière de Sérgio Paulo de Magalhães Simões
Anciens postes connus de Sérgio Paulo de Magalhães Simões
Sociétés | Poste | Début | Fin |
---|---|---|---|
University of Coimbra | Corporate Officer/Principal | - | - |
Formation de Sérgio Paulo de Magalhães Simões
University of Coimbra | Doctorate Degree |
Statistiques
Internationale
Portugal | 6 |
Opérationnelle
Chairman | 2 |
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Biocant Ventures SA
![]() Biocant Ventures SA Investment ManagersFinance Biocant Ventures SA (Biocant) is an Independent Venture Capital firm founded in 2006. The firm is headquartered in Cantanhede. | Finance |
Bluepharma Indústria Farmacêutica SA
![]() Bluepharma Indústria Farmacêutica SA Pharmaceuticals: MajorHealth Technology Bluepharma Indústria Farmacêutica SA develops, manufactures, and markets pharmaceutical drugs The firm operates through the following business areas: Production of Pharmaceutical Drugs for Bluepharma and Other Companies; Research, Development, and Registration of Pharmaceutical Drugs; and Marketing of Generic Pharmaceutical Drugs. Its services include licensing, contract manufacturing, product development, and research and development. The company was founded in February 2001 and is headquartered in Coimbra, Portugal. | Health Technology |
Luzitin SA
![]() Luzitin SA Pharmaceuticals: MajorHealth Technology Luzitin SA provides photodynamic therapy and photodiagnosis solutions. The firm develops new compounds to improve the efficiency of photodynamic therapy in the treatment of cancer. The company was founded by Luís Arnaut in 2010 and is headquartered in Coimbra, Portugal. | Health Technology |
Treat U SA
![]() Treat U SA BiotechnologyHealth Technology Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal. | Health Technology |